Incidental detection of gallbladder carcinoma in third trimester of pregnancy

Authors

  • Harleen Oberoi Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
  • Amrit Pal Kaur Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
  • Kiranjeet Kaur Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251330

Keywords:

Gall bladder cancer, PET CT, Metastasis

Abstract

Gall bladder cancer (GBC) represents the most common biliary tract cancer. GBCs are diagnosed more frequently in women. GB cancer represents a progression from dysplasia, to carcinoma in situ, to invasive carcinoma over about 15 years. Severe dysplasia and carcinoma in situ have been found in more than 90% of gallbladders that contain GB cancer. A 35-year-old G2P1L1 @34.4 weeks with previous 1 lower segment caesarean section (LSCS) came to emergency referred from a primary health center in view of pain abdomen. She was worked up and was found out to have deranged liver functions but no visible icterus, ultrasound whole abdomen showed GB mass with multiple heterogenous hypoechoic round to oval targeted lesions largest measuring 3.5×3 cm suggestive of metastasis. Patient was taken up for LSCS at 36 weeks. Post-operative period was uneventful until day 3 when patient started complaining of pain epigastrium with mild abdominal distention. Contrast enhanced computed tomography (CECT) was done which proved it to be a metastatic GB cancer. GB cancer during pregnancy is rare but challenging to manage. Diagnostic imaging, like ultrasound is mostly the safest and first line approach. The prognosis of stage 4 gallbladder cancer in pregnancy depends on various factors, including the extent of metastasis, the patient’s overall health, and the timing of diagnosis and treatment. Generally, stage 4 gallbladder cancer has a poor prognosis, with low survival rates even outside of pregnancy.

Metrics

Metrics Loading ...

References

Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades–an analysis of 10301 patients. Ann Surg Oncol. 2007;14(2):827-32. DOI: https://doi.org/10.1245/s10434-006-9224-4

World Health Organization. Gallbladder factsheet (2020). International Agency for Research and Cancer. Available at: https://gco.iarc.fr/today/data/ factsheets/cancers/12-Gallbladder-fact-sheet.pdf. Accessed on 20 January 2025.

Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20(1):146-59. DOI: https://doi.org/10.1093/annonc/mdn533

Goetze TO, Paolucci V. Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German registry. Surg Endosc. 2010;24(9):2156-64. DOI: https://doi.org/10.1007/s00464-010-0914-4

Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;7:99-109. DOI: https://doi.org/10.2147/CLEP.S37357

Batra Y, Pal S, Dutta U, Desai P, Garg PK, Makharia G, et al. Gallbladder cancer in India: a dismal picture. J Gastroenterol Hepatol. 2005;20(2). DOI: https://doi.org/10.1111/j.1440-1746.2005.03576.x

Levy AD, Murakata LA , Rohrmann CA . Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21(2):1-7. DOI: https://doi.org/10.1148/radiographics.21.2.g01mr16295

Eli Lilly. Gemzar product information. 2019. Available at: https://pi.lilly.com/us/gemzar.pdf. Accessed on 20 January 2025.

Eudaly JA, Tizzano JP, Higdon GL, Todd GC. Developmental toxicity of gemcitabine, an antimetabolite oncolytic, administered during gestation to CD-1 mice. Teratology. 1993;48(4):365-81. DOI: https://doi.org/10.1002/tera.1420480410

Collins K, Dong R, Rozenshteyn F, Lung E. 1328 intrauterine pregnancy complicated by a distal common bile duct mass: An unlikely diagnosis of extrahepatic cholangiocarcinoma with intrahepatic metastasis. Off J Am Coll Gastroenterol. 2019;114:S735. DOI: https://doi.org/10.14309/01.ajg.0000594840.35200.6d

Mishra PK, Saluja SS, Prithiviraj N, Varshney V, Goel N, Patil N. Predictors of curative resection and long term survival of gallbladder cancer - A retrospective analysis. Am J Surg. 2017;214(2):278-86. DOI: https://doi.org/10.1016/j.amjsurg.2017.02.006

La Vecchia C, Negri E, Franceschi S, Parazzini F: Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993;53(2):215-9. DOI: https://doi.org/10.1002/ijc.2910530207

Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003;12(4):269-72. DOI: https://doi.org/10.1097/00008469-200308000-00005

Rajput D, Gupta A, Gupta S, Rai A, Shasheendran S. The State of Perplexity During Management of Gall Bladder Malignancy in an Expectant Young Mother. 2021;13(2):e1309. DOI: https://doi.org/10.7759/cureus.13099

Downloads

Published

2025-04-29

How to Cite

Oberoi, H., Kaur, A. P., & Kaur, K. (2025). Incidental detection of gallbladder carcinoma in third trimester of pregnancy. International Journal of Research in Medical Sciences, 13(5), 2173–2175. https://doi.org/10.18203/2320-6012.ijrms20251330

Issue

Section

Case Reports